Evidence map›Paper›PMID 35951264›Full record

ReviewTopics in current chemistry (Cham)2022

Sustainable Solvent-Free Diels-Alder Approaches in the Development of Constructive Heterocycles and Functionalized Materials: A Review.

Aluru Rammohan, Alexey P Krinochkin, Albert F Khasanov, Dmitry S Kopchuk, Grigory V Zyryanov

Abstract readReview
PubMed Publisher
In one paragraph

Review in Topics in current chemistry (Cham), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Aluru RammohanUral Federal University, 19 Mira St., Ekaterinburg, 620002, Russian Federation. rammohan4ever@gmail.com.ORCID http://orcid.org/0000-0002-8624-6209
Alexey P KrinochkinUral Federal University, 19 Mira St., Ekaterinburg, 620002, Russian Federation.
Albert F KhasanovUral Federal University, 19 Mira St., Ekaterinburg, 620002, Russian Federation.
Dmitry S KopchukUral Federal University, 19 Mira St., Ekaterinburg, 620002, Russian Federation.
Grigory V ZyryanovUral Federal University, 19 Mira St., Ekaterinburg, 620002, Russian Federation. gvzyryanov@gmail.com.ORCID http://orcid.org/0000-0002-5982-8983
Ural Federal University · RU

Funding

Council on grants of the President of the Russian Federation NSh-1223.2022.1.3
6 · The paper itself

Abstract

The Diels-Alder reaction (DAR) is found in myriad applications in organic synthesis and medicinal chemistry for drug development, as it is the method of choice for the expedient synthesis of complex natural compounds and innovative materials including nanomaterials, graphene expanses, and polymeric nanofibers. Furthermore, the greatest focus of attention of DARs is on the consistent reaction procedure with stimulus yields by highly stereo- and regioselective mechanistic pathways. Therefore, the present review is intended to summarize conventional solvent-free (SF) DARs for the expedient synthesis of heterocyclic compounds and materials. In particular, this review deals with the DARs of mechanochemical grinding, catalysis (including stereoselective catalysts), thermal, and electromagnetic radiation (such as microwave [MW], infrared [IR], and ultraviolet [UV] irradiation) in SF procedures. Therefore, this comprehensive review validates the application of DARs to pharmaceutical innovations and biorenewable materials through consistent synthetic approaches.

Indexed as

SolventsCatalysisChemistry Techniques, SyntheticCycloaddition ReactionStereoisomerismSolventsCycloadditionDiels–Alder reaction (DAR)Solvent-free (SF)StereoselectivityThermal reaction

Identifiers

PMID35951264
OpenAlexW4292475910

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.